➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
Express Scripts
Harvard Business School
Merck

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Eplivanserin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Eplivanserin?

Eplivanserin is an investigational drug.

There have been 7 clinical trials for Eplivanserin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2005.

The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Sleep Wake Disorders, and Parasomnias. The leading clinical trial sponsors are Sanofi and [disabled in preview].

Recent Clinical Trials for Eplivanserin
TitleSponsorPhase
Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With InsomniaSanofiPhase 1
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance DifficultiesSanofiPhase 3
Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesSanofiPhase 3

See all Eplivanserin clinical trials

Clinical Trial Summary for Eplivanserin

Top disease conditions for Eplivanserin
Top clinical trial sponsors for Eplivanserin

See all Eplivanserin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
Express Scripts
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.